AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SUFENTANIL
17 registrations across 5 African markets— 10 active
Markets with SUFENTANIL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SUFENTA Solution injectable / 250 µg/5ml | 🇹🇳Tunisia | Piramal Critical Care B.V. | expired | Nov 2021 |
| SUFENTA Solution injectable / 50 µg/10ml | 🇹🇳Tunisia | Piramal Critical Care B.V. | expired | Jun 2021 |
| SUFENTA Solution injectable / 10 µg/2ml | 🇹🇳Tunisia | Piramal Critical Care B.V. | expired | Jun 2021 |
| SUFENTANIL VIATRIS Solution injectable / 50 µg/10ml | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jul 2017 |
| SUFENTANIL VIATRIS Solution injectable / 10µg/2ml | 🇹🇳Tunisia | VIATRIS SANTE | expired | Apr 2017 |
| SUFENTAMED Solution injectable / 10 µg/2 ml | 🇹🇳Tunisia | UNIMED | expired | Mar 2013 |
| SUFENTANIL MEDIS Solution injectable / 250 µg/5 ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Oct 2012 |
| PHARMA-Q SUFENTANIL INJECTION 10 ug/2 ml | 🇿🇦South Africa | Pharma-Q Holdings (Pty) Ltd | active | Jan 1900 |
| PHARMA-Q SUFENTANIL INJECTION 50 ug/10 ml | 🇿🇦South Africa | Pharma-Q Holdings (Pty) Ltd | active | Jan 1900 |
| SUFENTANIL BIOTIS PHARMA ampoule injectable / 10 mcg / 2 ml | 🇸🇳Senegal | BIOTIS PHARMA | active | — |
| SUFENTANIL BIOTIS PHARMA ampoule injectable / 250 mcg / 5 ml | 🇸🇳Senegal | BIOTIS PHARMA | active | — |
| SUFENTA SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SUFENTA 10µG /2ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SUFENTA SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SUFENTANIL RENAUDIN 10µG-2ML (5µG/ML) SI IV ET PERID BTE (10 solution injectable IV et | 🇲🇬Madagascar | RENAUDIN | active | — |
| SUFENTA 50 µG / 10 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SUFENTANIL RENAUDIN 10µG-2ML (5µG/ML) SI IV ET PERID BTE (10 solution injectable IV et | 🇲🇬Madagascar | RENAUDIN | active | — |
SUFENTANIL in Africa — Regulatory Overview
SUFENTANIL is registered across 5 African markets with 17 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Madagascar, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 17 registrations, 10 (59%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.